Saturday , 24 February 2018

Home » RESOURCES » INVESTING » Chipotle’s E. coli recovery could take years

Chipotle’s E. coli recovery could take years

Shares of Chipotle Mexican Grill Inc. fell nearly 2% in premarket trade Friday after the stock was downgraded to equal-weight from overweight at Morgan Stanley and its price target was reduced to $405 from $500. The downgrade comes in light of new evidence that show Chipotle’s sales recovery from the E. coli and salmonella outbreaks will “remain more protracted” than the market expects. “A full sales recovery to prior peak volumes could take years in our view,” said Morgan Stanley analyst John Glass. The analysis was conducted through an online survey of 2,000 U.S. consumers regarding how often they shop at Chipotle and other fast casual brands. Shares of Chipotle were on track to open around $411 on Friday. They’ve declined by 11% on the last three months and 37% on the year, underperforming the S&P 500. The average rating on the stock is the equivalent to hold, while the median 12-month price target is $451.89, according to a FactSet poll of more than 20 analysts.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Chipotle’s E. coli recovery could take years Reviewed by on . Shares of Chipotle Mexican Grill Inc. fell nearly 2% in premarket trade Friday after the stock was downgraded to equal-weight from overweight at Morgan Stanley Shares of Chipotle Mexican Grill Inc. fell nearly 2% in premarket trade Friday after the stock was downgraded to equal-weight from overweight at Morgan Stanley Rating:
scroll to top